Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

mkpatentcrmfinalMarketCRM

Drug Field of development:

Oncology Therapy Area:

Method Type of patent:

Mkpatentcrmfinalmarket

mkpatentcrmfinalMarket […]

BIO13310-T1

Drug Field of development:

Chronic Heart Failure Therapy Area:

Product Type of patent:

Apelin analogs for the treatment of heart failure

The invention related to metabolically stable Apelin analogs and their use for the prevention or the treatment of diseases mediated by the apelin […]

BIO17663-T1

Drug Field of development:

Dermatology Therapy Area:

Method Type of patent:

Methods and compositions for treating skin afflictions

The present invention relates to a method for treating skin afflictions in a subject comprising a step of administering said subject with a […]

BIO15274-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Methods and pharmaceutical compositions for inducing immune tolerance

The present invention relates to methods and pharmaceutical compositions of inducing immune tolerance by mucosal vaccination with Fc-coupled antigens. […]

BIO11035-T1

Drug Field of development:

Metabolic Disorders Therapy Area:

Target Type of patent:

Gaba administration induces alpha cell-mediated beta-like cell

GABA is an inducer of α-to-β-like cell conversion in vivo. This conversion induces α cell replacement mechanisms through the mobilization of […]

BIO19217-T1

Drug Field of development:

Hematological Disorders Therapy Area:

Product Type of patent:

Anti- protease nexin-1 conformational single domain antibodies and

The present invention relates to anti-protease nexin-1 (PN-1) conformational single domain antibodies and uses thereof in particular in the […]

BIO15170-T1

Drug Field of development:

Respiratory Disease Therapy Area:

Product Type of patent:

New antisense oligonucleotide targeting all cystic fibrosis patients

The present invention relates to methods and pharmaceutical compositions for the treatment of cystic fibrosis (CF). In particular, the present […]

BIO17336-T1

Drug Field of development:

Respiratory Disease Therapy Area:

Product Type of patent:

Methods and composition for the treatment of allergic asthma

The present invention relates to a method of treating allergic asthma in a subject in need thereof comprising a step of administering to said subject […]

BIO18240-T1

Drug Field of development:

Respiratory Disease Therapy Area:

Product Type of patent:

Antibodies specific for il20-rb and uses thereof for the treatment of

Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity and mortality worldwide. Acute exacerbation of COPD (AE-COPD) in […]

BIO13193-T2

Drug Field of development:

Multiple sclerosis Therapy Area:

Product Type of patent:

Antibody protecting from bscb leakage induced cns damages

The present invention relates to an anti-NMDA antibody or fragment or derivative thereof which is effective in inhibiting the deleterious effects of […]

147

56

310

46

Our Technology Offers

Mkpatentcrmfinalmarket

Apelin analogs for the treatment of heart failure

Methods and compositions for treating skin afflictions

Methods and pharmaceutical compositions for inducing immune tolerance

Gaba administration induces alpha cell-mediated beta-like cell

Anti- protease nexin-1 conformational single domain antibodies and

New antisense oligonucleotide targeting all cystic fibrosis patients

Methods and composition for the treatment of allergic asthma

Antibodies specific for il20-rb and uses thereof for the treatment of

Antibody protecting from bscb leakage induced cns damages

You might also be interested in

Mkpatentcrmfinalmarket

Methods and pharmaceutical compositions for

Methods and compositions for treating skin

Treatment of pregnant women affected with

Anti- protease nexin-1 conformational single

Correction of beta-thalassemia phenotype by

Antibodies specific for il20-rb and uses thereof

Selective pharmacological inhibition of epac1 for

Anti-cathepsin d human antibody for triple

Anti-nectin-4 monoclonal antibodies